PROFOUND MEDICAL CORP. Property Subject to or Available for Operating Lease, Net
PROFOUND MEDICAL CORP. (PROF) had Property Subject to or Available for Operating Lease, Net of $481.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Leases
us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet · last filed 2026-03-05
- 2025-12-31: Property Subject to or Available for Operating Lease, Net $481.00K.
- 2024-12-31: Property Subject to or Available for Operating Lease, Net $332.00K.
- 2023-12-31: Property Subject to or Available for Operating Lease, Net $751.00K.
| Period end | Property Subject to or Available for Operating Lease, Net |
|---|---|
| 2025-12-31 | $481.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $332.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $751.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |